Page last updated: 2024-10-30

mefenamic acid and Bone Cancer

mefenamic acid has been researched along with Bone Cancer in 2 studies

Mefenamic Acid: A non-steroidal anti-inflammatory agent with analgesic, anti-inflammatory, and antipyretic properties. It is an inhibitor of cyclooxygenase.
mefenamic acid : An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,3-dimethylphenyl group. Although classed as a non-steroidal anti-inflammatory drug, its anti-inflammatory properties are considered to be minor. It is used to relieve mild to moderate pain, including headaches, dental pain, osteoarthritis and rheumatoid arthritis.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
CAHILL, WJ1
HILL, RD1
JESSOP, J1
KENDALL, PH1
Hirota, Y1
Okamura, S1
Niho, Y1
Miyake, M1

Other Studies

2 other studies available for mefenamic acid and Bone Cancer

ArticleYear
TRIAL OF MEFENAMIC ACID.
    Annals of physical medicine, 1965, Volume: 8

    Topics: Analgesics; Analgesics, Non-Narcotic; Antipyretics; Arthritis; Arthritis, Rheumatoid; Bone Neoplasms

1965
[Mefenamic acid-induced autoimmune hemolytic anemia--a case report and review of literature].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1984, Volume: 25, Issue:12

    Topics: Anemia, Hemolytic, Autoimmune; Bone Neoplasms; Breast Neoplasms; Female; Humans; Mefenamic Acid; Mid

1984